Seizure News and Research

Latest Seizure News and Research

Stimulus-induced discharges in critically ill not linked to in-hospital death

Stimulus-induced rhythmic, periodic or ictal discharges in critically ill patients are not independently associated with in-hospital death, but are often associated with other electrographic abnormalities signalling poor outcomes, electroencephalography findings show.

17 Mar 2016

Orexigen Therapeutics, Valeant Pharmaceuticals sign distribution agreement for Mysimba

Orexigen Therapeutics, Inc. today announced Valeant Pharmaceuticals International, Inc. will commercialize Mysimba (naltrexone HCl / bupropion HCl prolonged release) in Central and Eastern Europe.

15 Mar 2016

Drexel University researchers explore effective drug for treating established status epilepticus

Drexel University College of Medicine researchers are conducting an emergency medicine study to find out the most effective drug for treating established status epilepticus -- a life-threatening condition in which the brain is in a state of persistent seizure.

14 Mar 2016

Heart rate variability may increase epilepsy risk

Doctors have long characterized epilepsy as a brain disorder, but researchers at Case Western Reserve University have found that part of the autonomic nervous system functions differently in epilepsy during the absence of seizures.This connection to the involuntary division of the nervous system may have implications for diagnosing and treating the disease and understanding sudden unexpected death in epilepsy

10 Mar 2016

Hemispheric and thalamic volumes point to electrical epilepticus during sleep

Early assessment of hemispheric and thalamic volumes in children with polymicrogyria and epilepsy can reliably predict the risk of continuous spike-and-wave complexes during sleep, a study indicates.

10 Mar 2016

New model could help to better understand extreme events in the brain

Physicists at the Universities of Bonn and Oldenburg have developed a model whose behavior - although based on strict rules - can apparently change spontaneously. There are also changes of this type in nature, for example, in the development of migraine attacks or epileptic seizures.

27 Feb 2016

ViiV Healthcare presents positive results from LATTE-2 study at CROI

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today presented positive results from the LATTE-2 study at the Conference on Retroviruses and Opportunistic Infections (CROI) in Boston. Headline results were announced in November 2015.

24 Feb 2016

Briviact (brivaracetam) approved for treatment of partial onset seizures in patients with epilepsy

The U.S. Food and Drug Administration yesterday approved Briviact (brivaracetam) as an add-on treatment to other medications to treat partial onset seizures in patients age 16 years and older with epilepsy.

22 Feb 2016

Electronic health records could help identify people who have undiagnosed type 2 diabetes

In 2012, a group of UCLA researchers set out to mine thousands of electronic health records for a more accurate and less expensive way to identify people who have undiagnosed type 2 diabetes. The researchers got much more than they bargained for.

16 Feb 2016

AES releases new guideline to help physicians treat status epilepticus patients effectively

Status epilepticus - continuous or rapid sequential seizure activity for 30 minutes or more - is a medical emergency with a high mortality rate in both children and adults. Prompt and effective treatment is key; therefore the American Epilepsy Society has released a new guideline to help physicians, hospitals, and health systems treat patients effectively.

10 Feb 2016

Medical marijuana offers hope for kids with uncontrolled seizures

Desperate for relief, parents are taking unusual steps to help children plagued with seizures. The relief, however, comes in a most unlikely form: marijuana.

9 Feb 2016

LouLou Foundation, Penn Med set up Program of Excellence to develop treatments for children with CDKL5

The London-based LouLou Foundation and the Orphan Disease Center of the Perelman School of Medicine at the University of Pennsylvania have established a Program of Excellence to develop effective treatments for children with CDKL5, a rare X-chromosome-linked genetic disorder that causes severe neuro-developmental impairment and early-onset, difficult-to-control seizures.

8 Feb 2016

HIV protein alters activity of networked neurons

Nearly half of HIV infected patients suffer from impaired neurocognitive function. The HIV protein transactivator of transcription (Tat) is an important contributor to HIV neuropathogenesis because it is a potent neurotoxin that continues to be produced despite treatment with antiretroviral therapy.

31 Jan 2016

Proton radiotherapy as effective as standard photon therapy in treating pediatric brain tumor

The use of proton radiotherapy to treat the most common malignant brain tumor in children is as effective as standard photon (x-ray) radiation therapy while causing fewer long-term side effects such as hearing loss and cognitive disorders, according to a study receiving online publication in Lancet Oncology.

30 Jan 2016

New computational techniques could help researchers pinpoint anatomical source of seizures

For the third of all epilepsy patients who don't respond to medication, an alternative is to locate the small cluster of neurons that act as the seed of a seizure's aberrant electrical activity and surgically remove it. Unfortunately, such surgeries often fail to bring any relief. The ability to reliably pinpoint the anatomical source of seizures, different for each patient, remains elusive.

29 Jan 2016

Results from STRIVE trial of enzalutamide versus bicalutamide in CRPC published in Journal of Clinical Oncology

Astellas US LLC, a United States (U.S.) subsidiary of Tokyo-based Astellas Pharma Inc., and Medivation, Inc. today announced that results from the STRIVE trial of enzalutamide compared to bicalutamide in men with castration-resistant prostate cancer (CRPC) were published in the Journal of Clinical Oncology.

27 Jan 2016

Upsher-Smith, Saniona sign drug discovery and development agreement

Upsher-Smith Laboratories, Inc., through its wholly-owned subsidiary Proximagen Ltd., and Saniona, a leading biotech company in the field of ion channels, today announce that they have entered into a drug discovery and development collaboration.

20 Jan 2016

Common mortality causes prevail in epilepsy patients

A prospective, community-based study confirms that patients with epilepsy usually die of the same causes as other people.

19 Jan 2016

Early promise for cannabis extract treatment in epilepsy

A preliminary, open-label study suggests that cannabidiol may be a useful adjunctive treatment in adults and children with intractable epilepsy.

7 Jan 2016

U.S. Marshals seize nearly 90,000 bottles of dietary supplements containing kratom

The U.S. Food and Drug Administration announced today that U.S. Marshals, at the agency's request, seized nearly 90,000 bottles of dietary supplements labeled as containing kratom. The product, manufactured for and held by Dordoniz Natural Products LLC, located in South Beloit, Illinois, is marketed under the brand name RelaKzpro and worth more than $400,000.

7 Jan 2016

Seizure News and Research

Latest Seizure News and Research

Stimulus-induced discharges in critically ill not linked to in-hospital death

Orexigen Therapeutics, Valeant Pharmaceuticals sign distribution agreement for Mysimba

Drexel University researchers explore effective drug for treating established status epilepticus

Heart rate variability may increase epilepsy risk

Hemispheric and thalamic volumes point to electrical epilepticus during sleep

New model could help to better understand extreme events in the brain

ViiV Healthcare presents positive results from LATTE-2 study at CROI

Briviact (brivaracetam) approved for treatment of partial onset seizures in patients with epilepsy

Electronic health records could help identify people who have undiagnosed type 2 diabetes

AES releases new guideline to help physicians treat status epilepticus patients effectively

Medical marijuana offers hope for kids with uncontrolled seizures

LouLou Foundation, Penn Med set up Program of Excellence to develop treatments for children with CDKL5

HIV protein alters activity of networked neurons

Proton radiotherapy as effective as standard photon therapy in treating pediatric brain tumor

New computational techniques could help researchers pinpoint anatomical source of seizures

Results from STRIVE trial of enzalutamide versus bicalutamide in CRPC published in Journal of Clinical Oncology

Upsher-Smith, Saniona sign drug discovery and development agreement

Common mortality causes prevail in epilepsy patients

Early promise for cannabis extract treatment in epilepsy

U.S. Marshals seize nearly 90,000 bottles of dietary supplements containing kratom

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Seizure News and Research

Latest Seizure News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in